67 pharma English-speaking jobs in Bavaria

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel

for going the extra mile, and a flat hierarchy About Prescient Healthcare Group Prescient is a pharma

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel

engagements Who You AreProven track record of leadership in quality assurance and project management in pharma

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel

ISO27000, NIST CSF, NIS2, PCI DSS, KRITIS / B3S PHARMA).• Demonstrated experience in developing and implementing

ISO27000, NIST CSF, NIS2, PCI DSS, KRITIS / B3S PHARMA).Demonstrated experience in developing and implementing

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel

automation solutions worldwide for various industries such as brewing, beverages, food, bakery, dairy, pharma

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel

In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel